TrialHypertension research : official journal of the Japanese Society of Hypertension2013

The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease.

Mai Yanagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.